A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Clinical Trials Drugs (Pharmaceuticals) Cancer Immune System Genetics and Heredity Tumors Source Type: news